Long Wang
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
[Corrigendum] Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation.
Journal: Molecular medicine reports
Published: January 16, 2017
Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation.
Journal: Molecular medicine reports
Published: January 16, 2017
Screening and validation of serum protein biomarkers for early postmenopausal osteoporosis diagnosis.
Journal: Molecular medicine reports
Published: December 13, 2016
Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats.
Journal: Stem cells and development
Published: December 06, 2016
Disturbed MEK/ERK signaling increases osteoclast activity via the Hedgehog-Gli pathway in postmenopausal osteoporosis.
Journal: Progress in biophysics and molecular biology
Published: December 19, 2015
GPR120: A bi-potential mediator to modulate the osteogenic and adipogenic differentiation of BMMSCs.
GPR120: A bi-potential mediator to modulate the osteogenic and adipogenic differentiation of BMMSCs.
Journal: Scientific reports
Published: June 29, 2015
Ginsenoside-Rb2 inhibits dexamethasone-induced apoptosis through promotion of GPR120 induction in bone marrow-derived mesenchymal stem cells.
Journal: Stem cells and development
Published: October 16, 2014
Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs.
Journal: Biochimie
Published: September 10, 2014
Protective effects of myricitrin against osteoporosis via reducing reactive oxygen species and bone-resorbing cytokines.
Journal: Toxicology and applied pharmacology
Published: May 15, 2014
Last Updated: 09/26/2026